GemPharmatech Presents Humanized Mouse Models to Support Bispecific Antibody and COVID-19 Preclinic Development at Biologics UK Oxford Global Conference

September 10, 2021

WILMINGTON, Del.--(BUSINESS WIRE) --GemPharmatech (GemPharmatech Co., Ltd. “GPT”) presented its humanized mouse models to support T-Cell Bispecific antibody and COVID-19 preclinic development and co-hosted a panel discussion on bispecific antibodies at Biologics UK Oxford Global Conference, London, UK, Sept. 6-8, 2021. The conference is the biggest in-person biologics event in London and was attended by hundreds of industrial and academic researchers and business partners from around the globe.

Read more at: